Parisa Zamiri
Geen lopende functies
Vermogen: 119 841 $ op 31-03-2024
Loopbaan van Parisa Zamiri
Eerdere bekende functies van Parisa Zamiri
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CALCIMEDICA, INC. | Chief Tech/Sci/R&D Officer | 01-06-2020 | 28-02-2023 |
| CALCIMEDICA, INC. | Chief Tech/Sci/R&D Officer | - | 28-02-2023 |
| NOVARTIS AG | Corporate Officer/Principal | 01-04-2012 | 01-06-2020 |
Arsenal Medical, Inc.
 Arsenal Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Arsenal Medical Inc. develops therapeutic products based on BioActive Composites platform. Its biomaterials-based systems provide targeted local and systemic therapies to treat chronic diseases and conditions. The firm product offers tailored dosing of drugs, mechanical and biochemical compatibility with tissues and complete bioabsorption. The company was founded by George M. Whitesides, Carmichael S. Roberts Jr. and Robert S. Langer Jr. in 2005 and is headquartered in Watertown, MA. | Corporate Officer/Principal | 01-02-2007 | 01-11-2011 |
Opleiding van Parisa Zamiri
| University College London | Doctorate Degree |
| King's College London | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Verenigd Koninkrijk | 3 |
| Zwitserland | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Graduate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| NOVARTIS AG | Health Technology |
| CALCIMEDICA, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Arsenal Medical, Inc.
Arsenal Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Arsenal Medical Inc. develops therapeutic products based on BioActive Composites platform. Its biomaterials-based systems provide targeted local and systemic therapies to treat chronic diseases and conditions. The firm product offers tailored dosing of drugs, mechanical and biochemical compatibility with tissues and complete bioabsorption. The company was founded by George M. Whitesides, Carmichael S. Roberts Jr. and Robert S. Langer Jr. in 2005 and is headquartered in Watertown, MA. | Commercial Services |
Graybug Vision, Inc.
 Graybug Vision, Inc. Pharmaceuticals: MajorHealth Technology Graybug Vision, Inc. develops ophthalmic drugs. It focus on developing drug delivery therapies for the treatment of eye diseases such as age-related macular degeneration and glaucoma. The company was founded by Justin S. Hanes, Peter John McDonnell, Christy Wyskiel and Peter A. Campochiaro in May 2011 and is headquartered in Redwood City, CA. | Health Technology |
- Beurs
- Insiders
- Parisa Zamiri
- Ervaring
